ArticleLiver cancer2021

Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma.

Chia-Lang Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.